HORIZON PHARMA PLC's ticker is and the CUSIP is G4617B905. A total of 3 filers reported holding HORIZON PHARMA PLC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,670,000 | -64.4% | 63,200 | -73.6% | 0.02% | -53.7% |
Q4 2018 | $4,686,000 | +9.6% | 239,800 | +9.8% | 0.04% | +20.6% |
Q3 2018 | $4,276,000 | +264.2% | 218,400 | +208.0% | 0.03% | +240.0% |
Q2 2018 | $1,174,000 | -51.3% | 70,900 | -58.2% | 0.01% | -58.3% |
Q1 2018 | $2,410,000 | -13.7% | 169,700 | -11.3% | 0.02% | +20.0% |
Q4 2017 | $2,793,000 | +86.3% | 191,300 | +61.8% | 0.02% | +42.9% |
Q3 2017 | $1,499,000 | +36.6% | 118,200 | +27.9% | 0.01% | +27.3% |
Q2 2017 | $1,097,000 | -58.1% | 92,400 | -47.8% | 0.01% | -63.3% |
Q1 2017 | $2,616,000 | -89.9% | 177,000 | -88.9% | 0.03% | -88.0% |
Q4 2016 | $25,805,000 | +377.0% | 1,594,900 | +434.5% | 0.25% | +323.7% |
Q3 2016 | $5,410,000 | +31.2% | 298,400 | +19.2% | 0.06% | +20.4% |
Q2 2016 | $4,122,000 | +116.8% | 250,300 | +118.2% | 0.05% | +81.5% |
Q1 2016 | $1,901,000 | -68.4% | 114,700 | -58.7% | 0.03% | -62.0% |
Q4 2015 | $6,020,000 | -33.8% | 277,800 | -39.5% | 0.07% | -43.7% |
Q3 2015 | $9,097,000 | +54.9% | 459,000 | +171.6% | 0.13% | +53.7% |
Q2 2015 | $5,871,000 | +4.4% | 169,000 | -22.0% | 0.08% | -6.8% |
Q1 2015 | $5,625,000 | +90.9% | 216,600 | -5.2% | 0.09% | +100.0% |
Q4 2014 | $2,947,000 | +67.0% | 228,600 | +59.1% | 0.04% | +63.0% |
Q3 2014 | $1,765,000 | – | 143,700 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 177,000 | $2,616,000 | 0.03% |
SIMPLEX TRADING, LLC | 1,619 | $109,000 | 0.01% |